Translation. Region: Russian Federation –
Source: Moscow Exchange – Moscow Exchange –
An important disclaimer is at the bottom of this article.
October 17, 2025 marks one year since the start of trading in shares of Ozon Pharmaceuticals PJSC (OZPH) on the Moscow Exchange.
The company's market capitalization has increased by one and a half times in a year and currently stands at 60 billion rubles.
The shareholder base has grown more than 3.5 times since the start of exchange trading and currently comprises over 150,000 private and institutional investors.
In June 2025, Ozon Pharmaceuticals conducted a secondary public offering (SPO) on the Moscow Exchange, which increased the free float of the company's shares from 10% to 14%.
The shares are included in the first quotation list of the Moscow Exchange and are included in the settlement bases Moscow Exchange Broad Market Index, Moscow Exchange Innovation Index and others.
Since February 2025, Ozon Pharmaceuticals shares have been included in List of securities of the high-tech (innovative) sector of the economy, which allows private investors who have continuously owned securities for at least one year to take advantage of an exemption from paying personal income tax on income from the sale of shares, subject to certain conditions.
In addition, the papers are included in Innovation and Investment Market Moscow Exchange (RII Sector) is an exchange sector for high-tech companies with significant growth potential.
The company's shares are available during the main, evening, and morning trading sessions of the Moscow Exchange stock market, as well as during an additional weekend session.
Congratulations to the company on its first anniversary of listing on the Moscow Exchange!
Ozon Pharmaceuticals Group is a leading Russian pharmaceutical group. The company's products span all pharmaceutical niches, including traditional small-molecule pharmaceuticals, treatments for cancer and complex autoimmune diseases, and high-tech biotech drugs. Ozon Pharmaceuticals' research laboratories are located in the Skolkovo biopharmaceutical cluster and in Khimki.
Moscow Exchange is Russia's largest exchange and the only multifunctional platform for trading stocks, bonds, derivatives, currencies, money market instruments, and commodities. The Moscow Exchange Group includes a central depository and a clearing center that acts as a central counterparty in the markets, enabling Moscow Exchange to provide its clients with a full range of trading and post-trading services.
Contact information for media: 7 (495) 363-3232PR@moex.com
Please note: This information is raw content obtained directly from the source. It represents an accurate account of the source's assertions and does not necessarily reflect the position of MIL-OSI or its clients.